What is the best treatment for bursitis (inflammation of the bursae)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The best treatment for bursitis typically involves a combination of rest, ice, compression, and elevation (RICE) of the affected area, along with over-the-counter pain relievers such as ibuprofen (Advil, Motrin) at 400-800mg three times daily or naproxen (Aleve) at 220-440mg twice daily for 1-2 weeks to reduce inflammation and pain. This approach is supported by the general principles of managing musculoskeletal symptoms, including those from tendonitis/bursitis, as outlined in the American Heart Association's scientific statement 1.

Key Considerations

  • Nonpharmacological approaches, such as physical therapy, heat/cold, and orthotics, should be the initial focus of treatment.
  • Pharmacological treatments, including NSAIDs, should be considered when nonpharmacological approaches are ineffective.
  • The choice of medication should be based on both safety and efficacy, with the least risky medication tried first.

Treatment Options

  • For more severe cases, corticosteroid injections directly into the bursa, such as methylprednisolone or triamcinolone, can provide significant relief within 24-48 hours.
  • Physical therapy exercises to strengthen surrounding muscles and improve range of motion are often beneficial once acute pain subsides.
  • In cases of septic bursitis (infection), antibiotics such as cephalexin 500mg four times daily for 7-10 days may be necessary.
  • For chronic or recurrent bursitis that doesn't respond to conservative measures, surgical removal of the bursa (bursectomy) might be considered.

Underlying Principles

The European League Against Rheumatism (EULAR) recommendations for managing psoriatic arthritis with pharmacological therapies also provide guidance on the use of NSAIDs and other treatments for musculoskeletal symptoms 1. While these recommendations are specific to psoriatic arthritis, they support the general principle of using NSAIDs to relieve musculoskeletal signs and symptoms. Additionally, the use of local injections of glucocorticoids as adjunctive therapy is recommended, which aligns with the consideration of corticosteroid injections for bursitis.

Evidence Base

The most recent and highest quality study relevant to the treatment of bursitis is from 2016, which provides recommendations for the management of psoriatic arthritis but also offers insights into the management of musculoskeletal symptoms more broadly 1. This study, along with others, supports the initial use of nonpharmacological approaches and NSAIDs for managing bursitis, reserving more invasive treatments like corticosteroid injections or surgery for more severe or refractory cases.

From the FDA Drug Label

For relief of the signs and symptoms of tendonitis For relief of the signs and symptoms of bursitis The recommended starting dose of naproxen is 500 mg, followed by 500 mg every 12 hours or 250 mg every 6 to 8 hours as required. The best treatment for bursitis is naproxen with a recommended starting dose of 500 mg, followed by 500 mg every 12 hours or 250 mg every 6 to 8 hours as required 2.

  • Key points:
    • Naproxen is indicated for relief of the signs and symptoms of bursitis 2
    • The recommended dose is 500 mg, followed by 500 mg every 12 hours or 250 mg every 6 to 8 hours as required 2
    • Naproxen has been studied in patients with bursitis and has been shown to be effective in relieving symptoms 2

From the Research

Treatment Options for Bursitis

  • Nonsurgical management, including ice, activity modification, and nonsteroidal anti-inflammatory drugs, is often effective for most patients with bursitis 3
  • Local corticosteroid injection may be used in the management of prepatellar and olecranon bursitis, but steroid injection into the retrocalcaneal bursa may adversely affect the biomechanical properties of the Achilles tendon 3
  • Surgical intervention may be required for recalcitrant bursitis, such as refractory trochanteric bursitis 3

Specific Treatment Options for Trochanteric Bursitis

  • Conservative measures, such as physical therapy and nonsteroidal anti-inflammatory drugs, are often effective for trochanteric bursitis 4
  • Corticosteroid injection can be used as a primary treatment modality, with symptom resolution and return to activity ranging from 49% to 100% 4
  • Low-energy shock-wave therapy (SWT) has been found to be superior to other nonoperative modalities in some studies 4
  • Surgical options, such as bursectomy, longitudinal release of the iliotibial band, and repair of gluteus medius tears, can be effective for persistent trochanteric bursitis 4

Treatment Options for Olecranon Bursitis

  • Conservative methods, such as rest, ice, compression, orthosis wear, and nonsteroidal anti-inflammatory medications, are often effective for olecranon bursitis 5
  • Intrabursal corticosteroid injections and surgical bursectomy have been used in the past, but more recent literature has demonstrated adverse effects of these treatments compared to noninvasive management 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Four common types of bursitis: diagnosis and management.

The Journal of the American Academy of Orthopaedic Surgeons, 2011

Research

Efficacy of treatment of trochanteric bursitis: a systematic review.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 2011

Research

Clinical Management of Olecranon Bursitis: A Review.

The Journal of hand surgery, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.